Search Results for: About
Alongside claims of natural ingredients, consumers are looking for brands that are serious about sustainability. As consumers grow more conscious of their ecological impact, they prioritize eco-friendly choices. Are your ingredient suppliers meeting consumer standards?
Alongside claims of natural ingredients, consumers are looking for brands that are serious about sustainability. As consumers grow more conscious of their ecological impact, they prioritize eco-friendly choices.
Produced at the Gnosis by Lesaffre Italian plant, MenaQ7® vitamin K2 adheres to the Environmental Management System, ISO 14001, and the Occupational Health and Safety Management System ISO 45001 standards.
After comprehensive assessments, we identified specific steps in our process where improvements can be made to improve energy efficiency. Our ongoing commitment involves substantial investments in sustainable practices to minimize environmental impact. In this piece, we provide an overview of the actions we take to ensure we reduce our ecological footprint effectively.
Our Sustainability Initiatives
- CO2 & Energy Reduction: A core commitment for Gnosis is to reduce our carbon footprint. Through investments in various systems, we recover condensates, minimize purge water, and anticipate a 5% reduction in electricity consumption by 2024.
- Water Reduction: In 2024, a project targeting a 20% reduction in water usage for cooling steam condensate will be implemented. Additionally, we already reuse wastewater to limit freshwater consumption.
- Waste Management: Implementing effective procedures, we actively reduce waste by providing pre-treated waste solvents through distillation, transforming them into secondary raw materials for external manufacturing sites.
Healthier People, Healthier Planet
While MenaQ7® stands out as the clinically proven vitamin K2 as MK-7, our commitment goes beyond efficacy. The brand has long catered to the evolving needs of supplement users: natural origin, vegan-friendly, GMO-free, allergen-free, and with a “free-from” approach to our product development.
Together, MenaQ7®‘s natural profile and Gnosis’ sustainable efforts offer a comprehensive value add, making it an ideal partner for supplement brands committed to a truly holistic approach to health for people and the planet alike.
> CHECK OUT OUR NEW VIDEO
This post highlights opportunities for brand owners based on key consumer trends for 2024. It is all about finding the optimal ingredient setting your product apart from the competition. We believe MenaQ7® is such an optimal ingredient. Consumers prioritize ingredients for better value According to Innova Market Insights “Ingredients Taking the Spotlight”, is at the … Continue reading Key Consumer Trends to Pay Attention to in 2024
This post highlights opportunities for brand owners based on key consumer trends for 2024. It is all about finding the optimal ingredient setting your product apart from the competition. We believe MenaQ7® is such an optimal ingredient.
Consumers prioritize ingredients for better value
According to Innova Market Insights “Ingredients Taking the Spotlight”, is at the top of their identified consumer trend of 2024. In other words, the hero of the product is the ingredients within it. Consumers look for value in the ingredients within the product and one-third of consumers report looking at the ingredients of interest on the product packaging.
Despite the cost-of-living crisis, FMCG Gurus also highlights value as a key trend with consumers. Specifically, consumers seek value in the form of efficacy, quality, and convenience. They ask questions like; does the product serve my needs, is efficacy-proven, is it trustworthy and is the dose form appealing? A key takeaway from FMCG Gurus is that value is more important to consumers than the lowest price, and brands should focus on innovation rather than being a cheaper “me-too” product.
Consumers Prioritize Prevention and Look for Clinically Proven Ingredients
According to Innova Market 1 in 3 global consumers report being more proactive when it comes to their health and prioritize a strategy of prevention when it comes to their physical health. When asked what their major concerns related to physical health are, the response was 1: Weight Management 2: Heart Health 3: Bone and Joint Health.
As consumers are getting more educated, higher inspection of your product is taking place. Consumers expect evidence and proof of the efficacy relating to the claims attached to a product. Brand owners who can provide evidence and documentation as part of their product information will be in a stronger position to build trust with consumers. Choosing branded ingredients with clinical documentation is crucial in meeting this demand.
Natural Ingredients and Sustainability
Beyond proven and science-backed claims, consumers are still looking for natural ingredients that are free from artificial additives, preservatives, and chemicals. Consumers are increasingly conscious of the impact of their choices on personal health and the environment. Features like Organic and non-GMO are often associated with a holistic approach to health and well-being, resonating with consumers seeking a more natural and integrated approach to their health. FMCG Gurus highlights a growing focus on ingredient transparency, where consumers are increasingly attentive to product labels and seeking healthy, clean, and recognizable ingredients.
How MenaQ7® Align with Consumer Demands
With MenaQ7® we are very confident your product will be equipped with the tools to meet the scrutiny of today’s health-conscious consumer.
With 22+ published clinical studies, and more underway, it is the most clinically proven Vitamin K2 as MK-7 in the market, and the only clinically proven for both bone and cardiovascular health. Our core focus is to translate complex clinical data from our research into compelling marketing tools, offering robust support to our customers.
MenaQ7® is derived by a fermentation process that mimics how nature produces vitamin K2 as MK-7. The MenaQ7® portfolio is complete with free from attributes, including all known allergens, it is vegan-friendly and of course non-GMO.
Through in-house production, Gnosis ensures 100% transparency allowing for complete traceability and control throughout the production process. And you are welcome to have a closer look.
With the most comprehensive K2 Solutions Platform, the clinically proven health benefits of MenaQ7® can effectively be incorporated into a range of new and increasingly sought-after products such as gummies, chewables, dispersible powders, and more.
Choose MenaQ7® in your next product development and enjoy the confidence of a carefully-made marketing story and messaging that will earn consumers trust in your brand.
Reach out today and let us start the conversation.
An epidemiological study has revealed an increase in bone mineral density in women and men over 60 in less than one decade. A new published in the Journal of Bone and Mineral Research has yielded findings demonstrating that continued education and encouragement about dietary supplement consumption works! The authors analyzed data from one of the … Continue reading Study Shows Proactive Supplementation Keeps Bones Healthy
An epidemiological study has revealed an increase in bone mineral density in women and men over 60 in less than one decade.
A new published in the Journal of Bone and Mineral Research has yielded findings demonstrating that continued education and encouragement about dietary supplement consumption works! The authors analyzed data from one of the longest-running epidemiological studies into osteoporosis – the Dubbo Osteoporosis Epidemiology Study (DOES). This study includes more than 3,000 adults 60 and older who were tracked for several years in two time sets: 1988-1992 and 1999-2001.
The results showed a dramatic difference in bone health between the two cohorts. The latter group showed a 3% increase in bone mineral density from the previous cohort. And the latter group had a 45% reduction in hip fractures. This improved bone mineral density status reflects a more proactive mindset to utilize available tools and lifestyle adaptation to protect bone health during aging. Since 2013, one tool has gained tremendous global awareness – Vitamin K2 as MK-7 (as MenaQ7®).
The DOES substantiates a landmark three-year study in healthy menopausal women who consumed 180 mcg MenaQ7 or placebo daily. Results were remarkable: the researchers found a statistically significant reduction in the rate at which age-related bone mineral density and content were lost in femoral neck (hip) and lumbar spine.
Taken together, the 2013 study and the epidemiological findings create a powerful case for K2 to be a required nutrient to support bone health.
Once again MenaQ7® is leading the efforts to validate the benefits of Vitamin K2 as MK-7 to support cardiovascular health. At the prestigious European Society of Cardiology Congress, PhD student from CARIM School for Cardiovascular Diseases at Maastricht University, Femke de Vries, presented an abstract from a post-hoc analysis of the previously published 1-year MenaQ7 … Continue reading New MenaQ7® Evidence Presented at the ESC Congress; further Solidifies Cardiovascular Benefits
Once again MenaQ7® is leading the efforts to validate the benefits of Vitamin K2 as MK-7 to support cardiovascular health. At the prestigious European Society of Cardiology Congress, PhD student from CARIM School for Cardiovascular Diseases at Maastricht University, Femke de Vries, presented an abstract from a post-hoc analysis of the previously published 1-year MenaQ7 cardiovascular study. The presentation sparked a lot of discussion about the publication of the post-hoc analysis expected later this year.
In the post-hoc analysis, the authors aimed to examine how supplementation of Vitamin K2 as MK-7 affected vascular stiffness in women going through pre-, peri-, and post-menopausal stages. The trial included 166 women (age 40-70 with low K2 status) who consumed 180 mcg MK-7 daily or placebo for one year.
Much-Needed Research on Heart Health in Women
Research on this specific demographic is critical. While cardiovascular disease has been considered a “man’s disease,” it is still the major cause of death in women over the age of 65, and research has been underrepresented.
The findings presented via the poster named “Beneficial Effects of One-Year Supplementation with Menaquinone-7 on Vascular Health and Blood Pressure in Post-Menopausal Women,” confirm a correlation between hormonal changes and their impact on the vasculature.
Post-menopausal women may experience heightened vascular stiffness, which can manifest as functional vascular damage. Arterial stiffness is a significant indicator of cardiovascular health, particularly in relation to blood pressure. Interestingly, it seems that enhancing one’s K2 status may positively influence both.
The abstract has been published in the European Heart Journal and is available on ESC 365, the cardiology knowledge hub. The post-hoc analysis will be published in a peer-reviewed journal later this year.
Get Your Science from the Source
At Gnosis, we are thrilled that our flag ship brand, MenaQ7, once again is leading the way in the validation of Vitamin K2 as MK-7’s critical role in supporting human health.
When it comes to formulating for heart health, we encourage you to get your science from the source and choose MenaQ7® Vitamin K2.
After this year’s A4M Spring Conference, Prof. Leon Schurgers sat with host Erika Schwartz, MD, to have an in-depth conversation about his research and how Vitamin K2 as MK-7 can be part of a holistic and integrative approach to health and well-being. Redefining Medicine is an intimate and personalized program that shows a different side … Continue reading Prof Leon Schurgers on A4M Redefining Medicine Podcast
After this year’s A4M Spring Conference, Prof. Leon Schurgers sat with host Erika Schwartz, MD, to have an in-depth conversation about his research and how Vitamin K2 as MK-7 can be part of a holistic and integrative approach to health and well-being.
Redefining Medicine is an intimate and personalized program that shows a different side of the practice of medicine. The conversation with Prof. Leon Schurgers did not fail to deliver.
Enjoy the podcast to learn how Prof. Schurgers work began with vitamin K, the facts that have been elucidated during his illustrious career, as well as a view of how he, as a researcher, works closely with clinicians at Maastricht University.
> Watch the Podcast
The global concern surrounding cardiovascular health continues to grow, prompting many of us to explore the supportive benefits offered by dietary supplementation. In recent years, researchers have placed a significant emphasis on understanding the role of arterial stiffness in cardiovascular health. Additionally, they have made groundbreaking discoveries regarding the vitamin K-dependent protein Matrix Gla Protein … Continue reading The Significance of Prioritizing Heart Health and the Impact of MenaQ7® Vitamin K2
The global concern surrounding cardiovascular health continues to grow, prompting many of us to explore the supportive benefits offered by dietary supplementation. In recent years, researchers have placed a significant emphasis on understanding the role of arterial stiffness in cardiovascular health. Additionally, they have made groundbreaking discoveries regarding the vitamin K-dependent protein Matrix Gla Protein (MGP). Through its many clinical trials, MenaQ7® is the vitamin K2 brand shown to effectively activate this critical cardio-supporting protein.
Vitamin K2 and Matrix Gla Protein (MGP)
Matrix Gla Protein (MGP) stands out as the most powerful prohibitor of vascular calcification, provided that the body has sufficient Vitamin K2 to activate it. Unfortunately, with vitamin K2 being almost completely void from typical Western diets, it is no wonder most people have deficient or insufficient levels of vitamin K2.
The Clinically Proven Vitamin K2 as MK-7 for Heart Health
Enter MenaQ7®: the clinically proven Vitamin K2 as MK-7. Our pioneering studies – randomized, double-blind, placebo-controlled trials – have demonstrated the remarkable benefits of MenaQ7®. One groundbreaking study, over the course of three years, showed that daily consumption of a nutritional dose of 180 mcg of MenaQ7® inhibited age-related arterial stiffening and improved arterial elasticity — a key aspect of maintaining a healthy cardiovascular system.
By choosing MenaQ7® for your supplement brand, be assured your ingredient is backed by scientific evidence confirming it supports robust heart health.
Learn more about the power of MenaQ7® and how the essence of this ingredient meets the top selection criteria of supplement buyers: Proof that it works!